Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1987 Jun;79(6):1595–1600. doi: 10.1172/JCI112994

Circulating somatostatin. Physiological regulator of pancreatic function?

K Gyr, C Beglinger, E Köhler, U Trautzl, U Keller, S R Bloom
PMCID: PMC424476  PMID: 2884233

Abstract

The present study was designed to determine whether somatostatin is released into the circulation in sufficient amounts to regulate exocrine and endocrine pancreatic function and to evaluate the possible role of somatostatin as a hormonal regulator of the pancreas. Mean plasma somatostatin levels (SLI) increased from 11 +/- 2 pmol liter-1 to peak concentrations of 18 +/- 2 in six healthy male volunteers after a steak meal (P less than 0.05). Infusion of somatostatin inhibited hormone-induced exocrine pancreatic secretion and suppressed cerulein-stimulated pancreatic polypeptide (PP) secretion, but did not significantly change arginine-stimulated insulin and glucagon release at mean plasma somatostatin concentrations within the range seen after a meal. The amount of somatostatin released after a meal thus was of sufficient magnitude to inhibit exocrine pancreatic function and PP release. On the other hand, basal and arginine-stimulated glucagon and insulin secretions were not significantly affected by these plasma concentrations of intravenous somatostatin suggesting that the exocrine pancreas might be more sensitive to somatostatin than the islet cells. We conclude that somatostatin in concentrations within the range seen after a meal is a potent inhibitor of stimulated acinar cell function in man. The findings support the hypothesis that somatostatin acts as a true hormonal regulator.

Full text

PDF
1595

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arnold R., Lankisch P. G. Somatostatin and the gastrointestinal tract. Clin Gastroenterol. 1980 Sep;9(3):733–753. [PubMed] [Google Scholar]
  2. Baldissera F. G., Holst J. J., Jensen S. L., Krarup T. Distribution and molecular forms of peptides containing somatostatin immunodeterminants in extracts from the entire gastrointestinal tract of man and pig. Biochim Biophys Acta. 1985 Jan 28;838(1):132–143. doi: 10.1016/0304-4165(85)90259-4. [DOI] [PubMed] [Google Scholar]
  3. Baldissera F. G., Munoz-Perez M. A., Holst J. J. Somatostatin 1-28 circulates in human plasma. Regul Pept. 1983 Apr;6(1):63–69. doi: 10.1016/0167-0115(83)90135-0. [DOI] [PubMed] [Google Scholar]
  4. Beglinger C., Fried M., Whitehouse I., Jansen J. B., Lamers C. B., Gyr K. Pancreatic enzyme response to a liquid meal and to hormonal stimulation. Correlation with plasma secretin and cholecystokinin levels. J Clin Invest. 1985 May;75(5):1471–1476. doi: 10.1172/JCI111850. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Boden G., Sivitz M. C., Owen O. E., Essa-Koumar N., Landor J. H. Somatostatin suppresses secretin and pancreatic exocrine secretion. Science. 1975 Oct 10;190(4210):163–165. doi: 10.1126/science.1166308. [DOI] [PubMed] [Google Scholar]
  6. Colturi T. J., Unger R. H., Feldman M. Role of circulating somatostatin in regulation of gastric acid secretion, gastrin release, and islet cell function. Studies in healthy subjects and duodenal ulcer patients. J Clin Invest. 1984 Aug;74(2):417–423. doi: 10.1172/JCI111437. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gerich J. E., Patton G. S. Somatostatin. Physiology and clinical applications. Med Clin North Am. 1978 Mar;62(2):375–392. doi: 10.1016/s0025-7125(16)31813-2. [DOI] [PubMed] [Google Scholar]
  8. Hirst B. H., Conlon J. M., Coy D. H., Holland J., Shaw B. Comparison of the gastric exocrine inhibitory activities and plasma kinetics of somatostatin-28 and somatostatin-14 in cats. Regul Pept. 1982 Sep;4(4):227–237. doi: 10.1016/0167-0115(82)90115-x. [DOI] [PubMed] [Google Scholar]
  9. Keller U., Szöllösy E., Varga L., Gyr K. Pancreatic glucagon secretion and exocrine function (BT-PABA test) in chronic pancreatitis. Dig Dis Sci. 1984 Sep;29(9):853–857. doi: 10.1007/BF01318431. [DOI] [PubMed] [Google Scholar]
  10. Konturek S. J., Kwiecień N., Obtułowicz W., Bielański W., Oleksy J., Schally A. V. Effects of somatostatin-14 and somatostatin-28 on plasma hormonal and gastric secretory responses to cephalic and gastrointestinal stimulation in man. Scand J Gastroenterol. 1985 Jan;20(1):31–38. doi: 10.3109/00365528509089629. [DOI] [PubMed] [Google Scholar]
  11. Loud F. B., Holst J. J., Egense E., Petersen B., Christiansen J. Is somatostatin a humoral regulator of the endocrine pancreas and gastric acid secretion in man? Gut. 1985 May;26(5):445–449. doi: 10.1136/gut.26.5.445. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Mandarino L., Stenner D., Blanchard W., Nissen S., Gerich J., Ling N., Brazeau P., Bohlen P., Esch F., Guillemin R. Selective effects of somatostatin-14, -25 and -28 on in vitro insulin and glucagon secretion. Nature. 1981 May 7;291(5810):76–77. doi: 10.1038/291076a0. [DOI] [PubMed] [Google Scholar]
  13. Marco J., Correas I., Zulueta M. A., Vincent E., Coy D. H., Comaru-Schally A. M., Schally A. V., Rodríguez-Arnao M. D., Gómez-Pan A. Inhibitory effect of somatostatin-28 on pancreatic polypeptide, glucagon and insulin secretion in normal man. Horm Metab Res. 1983 Aug;15(8):363–366. doi: 10.1055/s-2007-1018725. [DOI] [PubMed] [Google Scholar]
  14. Meyer F. D., Gyr K., Häcki W. H., Beglinger C., Jeker L., Varga L., Kayasseh L., Gillessen D., Stalder G. A. The release of pancreatic polypeptide by CCK-octapeptide and some analogues in the dog. Gastroenterology. 1981 Apr;80(4):742–747. [PubMed] [Google Scholar]
  15. O'Shaughnessy D. J., Long R. G., Adrian T. E., Christofides N. D., Ghatei M. A., Sarson D. L., Bloom S. R. Somatostatin-14 modulates postprandial glucose levels and release of gastrointestinal and pancreatic hormones. Digestion. 1985;31(4):234–242. doi: 10.1159/000199205. [DOI] [PubMed] [Google Scholar]
  16. Penman E., Wass J. A., Medbak S., Morgan L., Lewis J. M., Besser G. M., Rees L. H. Response of circulating immunoreactive somatostatin to nutritional stimuli in normal subjects. Gastroenterology. 1981 Oct;81(4):692–699. [PubMed] [Google Scholar]
  17. Polonsky K. S., Shoelson S. E., Docherty H. M. Plasma somatostatin 28 increases in response to feeding in man. J Clin Invest. 1983 May;71(5):1514–1518. doi: 10.1172/JCI110907. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Reichlin S. Somatostatin. N Engl J Med. 1983 Dec 15;309(24):1495–1501. doi: 10.1056/NEJM198312153092406. [DOI] [PubMed] [Google Scholar]
  19. Schusdziarra V., Lawecki J., Ditschuneit H. H., Lukas B., Maier V., Pfeiffer E. F. Effect of low-dose somatostatin infusion on pancreatic and gastric endocrine function in lean and obese nondiabetic human subjects. Diabetes. 1985 Jun;34(6):595–601. doi: 10.2337/diab.34.6.595. [DOI] [PubMed] [Google Scholar]
  20. Solomon T. E. Regulation of pancreatic secretion. Clin Gastroenterol. 1984 Sep;13(3):657–678. [PubMed] [Google Scholar]
  21. Souquet J. C., Rambliere R., Riou J. P., Beylot M., Cohen R., Mornex R., Chayvialle J. A. Hormonal and metabolic effects of near physiological increase of plasma immunoreactive somatostatin 14. J Clin Endocrinol Metab. 1983 May;56(5):1076–1079. doi: 10.1210/jcem-56-5-1076. [DOI] [PubMed] [Google Scholar]
  22. Taparel D., Susini C., Esteve J. P., Diaz J., Cazaubon C., Vaysse N., Ribet A. Somatostatin analogs: correlation of receptor affinity with inhibition of cyclic AMP formation in pancreatic acinar cells. Peptides. 1985 Jan-Feb;6(1):109–114. doi: 10.1016/0196-9781(85)90085-3. [DOI] [PubMed] [Google Scholar]
  23. Unger R. H., Aguilar-Parada E., Müller W. A., Eisentraut A. M. Studies of pancreatic alpha cell function in normal and diabetic subjects. J Clin Invest. 1970 Apr;49(4):837–848. doi: 10.1172/JCI106297. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Vinik A. I., Levitt N. S., Pimstone B. L., Wagner L. Peripheral plasma somatostatin-like immunoreactive responses to insulin hypoglycemia and a mixed meal in healthy subjects and in noninsulin-dependent maturity-onset diabetics. J Clin Endocrinol Metab. 1981 Feb;52(2):330–337. doi: 10.1210/jcem-52-2-330. [DOI] [PubMed] [Google Scholar]
  25. Wiggins H. S. Simple method for estimating trypsin. Gut. 1967 Aug;8(4):415–416. doi: 10.1136/gut.8.4.415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. You C. H., Rominger J. M., Chey W. Y. Potentiation effect of cholecystokinin-octapeptide on pancreatic bicarbonate secretion stimulated by a physiologic dose of secretin in humans. Gastroenterology. 1983 Jul;85(1):40–45. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES